المؤلفون: Purri R; Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA., Brennan L; Department of Neurology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA., Rick J; Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA., Xie SX; Department of Biostatistics, Epidemiology, & Informatics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA., Deck BL; Department of Psychology, Drexel University, Philadelphia, Pennsylvania, USA., Chahine LM; Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Dahodwala N; Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA., Chen-Plotkin A; Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA., Duda JE; Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.; Parkinson's Disease Research, Education, and Clinical Center, Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA., Morley JF; Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.; Parkinson's Disease Research, Education, and Clinical Center, Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA., Akhtar RS; Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA., Trojanowski JQ; Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA., Siderowf A; Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA., Weintraub D; Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.; Parkinson's Disease Research, Education, and Clinical Center, Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA.; Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.

المصدر: Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2020 Sep; Vol. 35 (9), pp. 1618-1625. Date of Electronic Publication: 2020 Jun 10.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8610688 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-8257 (Electronic) Linking ISSN: 08853185 NLM ISO Abbreviation: Mov Disord Subsets: MEDLINE

مواضيع طبية MeSH: Cognitive Dysfunction*/diagnosis , Cognitive Dysfunction*/etiology , Parkinson Disease*/complications, Coal ; Cognition ; Humans ; Neuropsychological Tests

المؤلفون: Weintraub D; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Parkinson's Disease Research, Education and Clinical Center, Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania., Caspell-Garcia C; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa., Simuni T; Feinberg School of Medicine, Northwestern University, Chicago, Illinois., Cho HR; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa., Coffey CS; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa., Aarsland D; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, England., Alcalay RN; Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York., Barrett MJ; Department of Neurology, Virginia Commonwealth University, Richmond, Virginia., Chahine LM; Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Eberling J; Michael J. Fox Foundation for Parkinson's Research, New York, New York., Espay AJ; Department of Neurology, University of Cincinnati Academic Health Center, Cincinnati, Ohio., Hamilton J; Michael J. Fox Foundation for Parkinson's Research, New York, New York., Hawkins KA; Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut., Leverenz J; Lou Ruvo Center for Brain Health, Cleveland Clinic, Cleveland, Ohio., Litvan I; UCSD Movement Disorder Center, Department of Neurosciences, University of California San Diego, San Diego, California., Richard I; Departments of Neurology and Psychiatry, School of Medicine and Dentistry, University of Rochester, Rochester, New York., Rosenthal LS; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Siderowf A; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., York M; Departments of Neurology and Psychiatry & Behavioral Sciences, Baylor College of Medicine, Houston, Texas.

مؤلفون مشاركون: Parkinson’s Progression Markers Initiative

المصدر: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2020 Apr; Vol. 7 (4), pp. 449-461. Date of Electronic Publication: 2020 Apr 13.

نوع المنشور: Journal Article; Observational Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley Periodicals, Inc on behalf of American Neurological Association Country of Publication: United States NLM ID: 101623278 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2328-9503 (Electronic) Linking ISSN: 23289503 NLM ISO Abbreviation: Ann Clin Transl Neurol Subsets: MEDLINE

مواضيع طبية MeSH: Disease Progression*, Behavioral Symptoms/*physiopathology , Cognitive Dysfunction/*physiopathology , Parkinson Disease/*physiopathology, Adult ; Aged ; Aged, 80 and over ; Behavioral Symptoms/drug therapy ; Behavioral Symptoms/epidemiology ; Behavioral Symptoms/etiology ; Cognitive Dysfunction/drug therapy ; Cognitive Dysfunction/epidemiology ; Cognitive Dysfunction/etiology ; Female ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Parkinson Disease/complications ; Parkinson Disease/drug therapy ; Parkinson Disease/epidemiology ; Prevalence

المؤلفون: Tropea TF; Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Xie SX; Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Rick J; Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Chahine LM; Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Dahodwala N; Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Doshi J; Department of Radiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Davatzikos C; Department of Radiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Shaw LM; Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Van Deerlin V; Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Trojanowski JQ; Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Center for Neurodegenerative Disease Research, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Weintraub D; Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Parkinson's Disease and Mental Illness Research, Education and Clinical Centers (PADRECC and MIRECC), Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA., Chen-Plotkin AS; Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

المصدر: Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2018 Feb; Vol. 33 (2), pp. 289-297. Date of Electronic Publication: 2017 Nov 23.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8610688 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-8257 (Electronic) Linking ISSN: 08853185 NLM ISO Abbreviation: Mov Disord Subsets: MEDLINE

مواضيع طبية MeSH: Apolipoprotein E4/*genetics , Cognitive Dysfunction/*etiology , Cognitive Dysfunction/*genetics , Mutation/*genetics , Parkinson Disease/*complications , Parkinson Disease/*genetics, Aged ; Cohort Studies ; Cross-Sectional Studies ; Female ; Genotype ; Humans ; Male ; Middle Aged ; Neuropsychological Tests ; Severity of Illness Index ; Statistics, Nonparametric

المؤلفون: Weintraub D; Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.; PD Research, Education and Clinical Center, Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA., Chahine LM; Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Hawkins KA; Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA., Siderowf A; Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Eberly S; Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, New York, USA., Oakes D; Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, New York, USA., Seibyl J; The Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA., Stern MB; Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Marek K; The Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA., Jennings D; Eli Lilly and Company, Indianapolis, Indiana, USA.

مؤلفون مشاركون: PARS Investigators

المصدر: Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2017 Nov; Vol. 32 (11), pp. 1640-1645. Date of Electronic Publication: 2017 Oct 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8610688 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-8257 (Electronic) Linking ISSN: 08853185 NLM ISO Abbreviation: Mov Disord Subsets: MEDLINE

مواضيع طبية MeSH: Disease Progression* , Prodromal Symptoms*, Cognitive Dysfunction/*physiopathology , Dopamine Plasma Membrane Transport Proteins/*metabolism , Olfaction Disorders/*physiopathology , Parkinson Disease/*metabolism , Parkinson Disease/*physiopathology, Aged ; Attention/physiology ; Executive Function/physiology ; Female ; Follow-Up Studies ; Humans ; Language Disorders/physiopathology ; Male ; Memory Disorders/physiopathology ; Memory, Short-Term/physiology ; Middle Aged ; Prognosis

المؤلفون: Caspell-Garcia C; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, United States of America., Simuni T; Feinberg School of Medicine, Northwestern University, Chicago, IL, United States of America., Tosun-Turgut D; University of California, San Francisco, San Francisco, CA, United States of America., Wu IW; University of California, San Francisco, San Francisco, CA, United States of America., Zhang Y; University of California, San Francisco, San Francisco, CA, United States of America., Nalls M; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, United States of America., Singleton A; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, United States of America., Shaw LA; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States of America., Kang JH; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States of America.; Department of Pharmacology & Clinical Pharmacology, Inha University School of Medicine, Incheon, Republic of Korea., Trojanowski JQ; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States of America., Siderowf A; Avid Radiopharmaceuticals, Philadelphia, PA, United States of America., Coffey C; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, United States of America., Lasch S; Institute for Neurodegenerative Disorders (IND) and Molecular NeuroImaging, LLC (MNI), New Haven CT, United States of America., Aarsland D; Department of Old Age Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, England.; Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway., Burn D; Institute for Ageing and Health, Newcastle University, Newcastle, England., Chahine LM; Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States of America., Espay AJ; Department of Neurology, University of Cincinnati Academic Health Center, Cincinnati, OH, United States of America., Foster ED; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, United States of America., Hawkins KA; Department of Psychiatry, Yale School of Medicine, New Haven, CT, United States of America., Litvan I; UCSD Movement Disorder Center, Department of Neurosciences, University of California San Diego, San Diego, CA, United States of America., Richard I; Departments of Neurology and Psychiatry, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America., Weintraub D; Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States of America.; Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States of America.; Parkinson's Disease Research, Education and Clinical Center (PADRECC and MIRECC), Philadelphia Veterans Affairs Medical Center, Philadelphia, PA, United States of America.; Mental Illness Research, Education and Clinical Center (MIRECC), Philadelphia Veterans Affairs Medical Center, Philadelphia, PA, United States of America.

مؤلفون مشاركون: Parkinson’s Progression Markers Initiative (PPMI)

المصدر: PloS one [PLoS One] 2017 May 17; Vol. 12 (5), pp. e0175674. Date of Electronic Publication: 2017 May 17 (Print Publication: 2017).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: Cognitive Dysfunction/*epidemiology , Parkinson Disease/*complications, Adult ; Aged ; Aged, 80 and over ; Amyloid beta-Peptides/cerebrospinal fluid ; Biomarkers/cerebrospinal fluid ; Brain-Derived Neurotrophic Factor/genetics ; Catechol O-Methyltransferase/genetics ; Cognitive Dysfunction/cerebrospinal fluid ; Cognitive Dysfunction/diagnostic imaging ; Cognitive Dysfunction/genetics ; Diffusion Tensor Imaging ; Dopamine Plasma Membrane Transport Proteins/metabolism ; Female ; Humans ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Polymorphism, Single Nucleotide ; Tomography, Emission-Computed, Single-Photon ; tau Proteins/cerebrospinal fluid

المؤلفون: Franzmeier N; Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-Universität LMU, Munich, Germany., Hartmann JC; Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-Universität LMU, Munich, Germany., Taylor ANW; Department of Psychology, University of Southampton, Southampton, UK., Araque Caballero MÁ; Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-Universität LMU, Munich, Germany., Simon-Vermot L; Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-Universität LMU, Munich, Germany., Buerger K; Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-Universität LMU, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE, Munich), Munich, Germany., Kambeitz-Ilankovic LM; Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-Universität LMU, Munich, Germany., Ertl-Wagner B; Institute for Clinical Radiology, Klinikum der Universität München, Ludwig-Maximilian University, Munich, Germany., Mueller C; Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-Universität LMU, Munich, Germany., Catak C; Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-Universität LMU, Munich, Germany., Janowitz D; Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-Universität LMU, Munich, Germany., Stahl R; Institute for Clinical Radiology, Klinikum der Universität München, Ludwig-Maximilian University, Munich, Germany., Dichgans M; Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-Universität LMU, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE, Munich), Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Duering M; Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-Universität LMU, Munich, Germany., Ewers M; Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-Universität LMU, Munich, Germany.

المصدر: Journal of Alzheimer's disease : JAD [J Alzheimers Dis] 2017; Vol. 59 (4), pp. 1381-1392.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: IOS Press Country of Publication: Netherlands NLM ID: 9814863 Publication Model: Print Cited Medium: Internet ISSN: 1875-8908 (Electronic) Linking ISSN: 13872877 NLM ISO Abbreviation: J Alzheimers Dis Subsets: MEDLINE

مواضيع طبية MeSH: Aging/*pathology , Cognitive Dysfunction/*pathology , Frontal Lobe/*pathology , Functional Laterality/*physiology , Memory/*physiology , Nerve Net/*pathology, Aged ; Aged, 80 and over ; Apolipoproteins E/genetics ; Brain Mapping ; Cognitive Dysfunction/diagnostic imaging ; Cognitive Dysfunction/genetics ; Face ; Female ; Frontal Lobe/diagnostic imaging ; Humans ; Image Processing, Computer-Assisted ; Magnetic Resonance Imaging ; Male ; Names ; Nerve Net/diagnostic imaging ; Neural Pathways/diagnostic imaging ; Pattern Recognition, Visual/physiology ; Sex Factors